Loading...
Chemical structure of MrgprX2 antagonist-1

GC65950

MrgprX2 antagonist-1

Also known as 3-[5-[(3,5-difluorophenyl)methyl]-1,3,4-thiadiazol-2-yl]-1-ethyl-1-[(2R)-3,3,3-trifluoro-2-hydroxypropyl]urea

MrgprX2 antagonist-1 is an MrgprX2 antagonist extracted from patent WO2021092264A1, example E23· MrgprX2 antagonist-1 can be used for the research of inflammatory disorders of the skin

ChemicalCAS2642162-06-7MW410.36FormulaC15H15F5N4O2S
CAS number
2642162-06-7
Molecular weight
410.36
Formula
C15H15F5N4O2S
Solubility
DMSO ： 66·67 mg/mL (162·47 mM; Need ultrasonic)
InChIKey
QJCRGWUNWPWJCQ-LLVKDONJSA-N
Catalogue number
GC65950
Brand
GLPBIO
Computed properties PubChem CID 162641702 · XLogP 2.9 · TPSA 107 Ų · H-bond donors 2
XLogP
2.9
TPSA
107 Ų
H-bond donors
2
H-bond acceptors
10
Rotatable bonds
6
Heavy atoms
27

SMILES CCN(C[C@H](C(F)(F)F)O)C(=O)NC1=NN=C(S1)CC2=CC(=CC(=C2)F)F

Computed descriptors from PubChem (CID 162641702), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.